Lehigh Valley Health Network

What it reported doing in 2024

Lehigh valley hospital (lvh), part of jefferson health, is comprised of eight hospital campuses, including lvh - cedar crest, lvh - muhlenberg, lvh - 17th street, lehigh valley health network (lvhn) - tilghman, lvh - hecktown oaks, lvh - carbon, lvhn - highland and lvhn - 1503 n. Cedar crest. Lvh offers a continuum of programs in health care promotion, prevention, diagnosis, treatment, and rehabilitation to the community. Extensive inpatient, outpatient, and educational services are provided at locations throughout the region and are part of lehigh valley health network (lvhn). They were established to meet the medical, surgical, and educational needs of the residents of the lehigh valley and beyond. In fy25, lvhn continued to integrate and align with jefferson health.lvh serves as a referral center for approximately two million residents of surrounding counties in eastern Pennsylvania, with a special focus on the following key areas: lehigh valley topper cancer institute - when jefferson health and lvhn combined last year, the organization became one of the top fifteen not-for-profit health systems in the u.s., with thirty-two hospitals and more than seven hundred sites of care. The combination, which brought lehigh valley topper cancer institute into the fold, expanded jefferson healths's top-tier cancer care program beyond philadelphia into northeast Pennsylvania. Now it provides more patients with access to an evolving set of treatments and a broader network of specialists and cancer resources.some of the resources brought specifically by the cancer institute include the lehigh valley region's first stem cell transplant program; chimeric antigen receptor t-cell therapy (car-t), which fights cancer with the patient's own reengineered cells; histotripsy treatment, a noninvasive therapy that uses focused sound waves to destroy liver tumors; the hepatic artery infusion pump, a device that delivers chemotherapy directly into the hepatic artery, which supplies blood to the liver; and ai-driven radiation therapy, which offers superior imaging to better target treatment.in addition, the cancer institute is home base for clinical trials studying vaccines for both melanoma and pancreatic cancer.in may 2024, the cancer institute was recognized and accredited as an integrated network cancer program with the american college of surgeons commission on cancer. The cancer institute was commended for being "a role model for integrated network cancer programs." this highlights the excellent collaboration and expertise of all physicians and colleagues to bring together the different campuses of the health network to provide standardized, uniform, coordinated and consistent cancer care to our patients from all locations. In calendar year 2024, the cancer institute estimated 7,000 new analytic cancer cases. Inpatient oncology admissions were 3,872 in the fiscal year ending june 30, 2024, and outpatient volumes included 30,079 treatment visits for radiation procedures and 56,909 treatment visits for infusion visits. Lehigh valley heart and vascular institute - lehigh valley heart and vascular institute ended fy25 with another year of growth and advancements in cardiovascular care. These accomplishments reflect our dedication to clinical excellence, innovation, and commitment to elevating cardiovascular care locally for the patients we serve.programmatic milestones and new initiatives - the heart and vascular institute was part of several groundbreaking procedures and programmatic milestones this year. Lvhn was the first in the world to use a radial balloon dilation catheter and the first in the u.s. To utilize new 3d stent technology. We also performed our first renal denervation case, providing another treatment option for patients with drug-resistant uncontrolled hypertension.additionally, our subspeciality programs led by our surgical colleagues continue to advance. Our limb preservation program continues to develop to combat the disparities

Financial Efficiency

• Mission deployment rate: 85.9%; rating input score 86
• Program expense ratio: 95.8%; rating input score 96
• Fundraising efficiency: $6.07 raised per $1 spent on fundraising; rating input score 27; 27th percentile among comparable filings

Transparency & Controls

• Consistency checks: 100%; rating input score 100; 68th percentile among comparable filings
• Pay-setting controls: 5 of 6 controls in place; rating input score 83
  • Compensation committee: Pass
  • Independent consultant: Pass
  • Other Form 990s reviewed: Missing
  • Written employment contract: Pass
  • Compensation survey or study: Pass
  • Board or committee approval: Pass
• Foreign activity oversight: Limited
• Grant itemization coverage: 100%; rating input score 100; 77th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Limited

Accountability

• Independent voting board: 55.6%; rating input score 56; 15th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: 12.4%; rating input score 78; 78th percentile among comparable filings
• Total-asset coverage ratio: 1.06; rating input score 41; 41st percentile among comparable filings
• Liabilities to assets ratio: 0.43; rating input score 42; 42nd percentile among comparable filings
• Officer compensation ratio: 0.7%; rating input score 81; 81st percentile among comparable filings

Growth

• Program expense growth: 10.6% per year; rating input score 100; 76th percentile among comparable filings
• Revenue growth: 9.7% per year; rating input score 100; 75th percentile among comparable filings
• Asset growth: 8.1% per year; rating input score 100; 59th percentile among comparable filings